Latest Diabetes: Drugs news
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
posted August 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk
posted July 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes Related Articles
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM 
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition 
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM 
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
